428 assets in Triple-Negative Breast Carcinoma

Therapeutic assets addressing Triple-Negative Breast Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
nkt3447 Triple-Negative Breast Carcinoma	NiKang Therapeutics, Inc.	P1	C (37)
nkt3964 Triple-Negative Breast Carcinoma	NiKang Therapeutics, Inc.	P1	C (37)
nm1f Triple-Negative Breast Carcinoma	Hefei TG ImmunoPharma Co., Ltd.	P1	C (37)
nm32-2668 Triple-Negative Breast Carcinoma	Numab Therapeutics AG	P1	C (37)
Onm-501 Triple-Negative Breast Carcinoma	OncoNano Medicine, Inc.	P1	C (37)
Pba-0405 Triple-Negative Breast Carcinoma	Pure Biologics S.A.	Early P1	C (37)
pf-08032562 Triple-Negative Breast Carcinoma	Pfizer	P1	C (37)
Prednisone Triple-Negative Breast Carcinoma	Andrew Hantel, MD	P1	C (37)
Telisotuzumab Adizutecan Triple-Negative Breast Carcinoma	AbbVie	P1	C (37)
zm008 Triple-Negative Breast Carcinoma	Zumutor Biologics Inc.	P1	C (37)
Amcenestrant Triple-Negative Breast Carcinoma	QuantumLeap Healthcare Collaborative	P2	C (36)
Magrolimab Triple-Negative Breast Carcinoma	Gilead Sciences	P2	C (36)
Fosifloxuridine Nafalbenamide Triple-Negative Breast Carcinoma	NuCana plc	P1/2	C (35)
Cyclosporin A Triple-Negative Breast Carcinoma	Virginia G. Kaklamani	Early P1	C (34)
Epigallocatechin-3-Gallate Triple-Negative Breast Carcinoma	Ministry of Health, Saudi Arabia	Early P1	C (34)
Iohexol Triple-Negative Breast Carcinoma	Alison Stopeck	Early P1	C (34)
Pba-0111 Triple-Negative Breast Carcinoma	Pure Biologics S.A.	Early P1	C (34)
Zinc Triple-Negative Breast Carcinoma	Ministry of Health, Saudi Arabia	Early P1	C (34)
Aipalolitovorelizumab Triple-Negative Breast Carcinoma	The First Affiliated Hospital with Nanjing Medical University	N/A	D (30)
Bemotuzumab Triple-Negative Breast Carcinoma	Zhejiang Provincial People's Hospital	N/A	D (30)
App-111 Triple-Negative Breast Carcinoma	Veru Inc.	P2	D (29)
Imatinib Triple-Negative Breast Carcinoma	Vastra Gotaland Region	N/A	D (28)
225ac-tr2205 Triple-Negative Breast Carcinoma	Xiaorong Sun	Early P1	NR ()
9mw2821 Triple-Negative Breast Carcinoma	Mabwell (Shanghai) Bioscience Co., Ltd.	P3	NR ()
Live Biotherapeutic Product: Mo-03 1 Po Bid Triple-Negative Breast Carcinoma	Yuan Yuan	P2	NR ()
Zn-Telomir Triple-Negative Breast Carcinoma	Telomir Pharmaceuticals, Inc.	P1/2	NR ()

Showing 401 to 428 of 428 assets

PreviousPage 9 of 9Next